AU2001292499A1 - 7-chloro-4-hydroxy-2-(2-pyridylethyl)-1,2,5,10- tetrahydropyridazino(4,5-b)quinoline-1,10-dione and the use thereof for the treatment of pain - Google Patents
7-chloro-4-hydroxy-2-(2-pyridylethyl)-1,2,5,10- tetrahydropyridazino(4,5-b)quinoline-1,10-dione and the use thereof for the treatment of painInfo
- Publication number
- AU2001292499A1 AU2001292499A1 AU2001292499A AU9249901A AU2001292499A1 AU 2001292499 A1 AU2001292499 A1 AU 2001292499A1 AU 2001292499 A AU2001292499 A AU 2001292499A AU 9249901 A AU9249901 A AU 9249901A AU 2001292499 A1 AU2001292499 A1 AU 2001292499A1
- Authority
- AU
- Australia
- Prior art keywords
- pain
- tetrahydropyridazino
- pyridylethyl
- dione
- quinoline
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US23663000P | 2000-09-29 | 2000-09-29 | |
US60236630 | 2000-09-29 | ||
PCT/SE2001/002125 WO2002026740A1 (fr) | 2000-09-29 | 2001-09-28 | 7-chloro-4-hydroxy-2-(2-pyridylethyl)-1,2,5,10-tetrahydropyridazino[4,5-b]quinoline-1,10-dione et son utilisation pour le traitement de la douleur |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001292499A1 true AU2001292499A1 (en) | 2002-04-08 |
Family
ID=22890309
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001292499A Abandoned AU2001292499A1 (en) | 2000-09-29 | 2001-09-28 | 7-chloro-4-hydroxy-2-(2-pyridylethyl)-1,2,5,10- tetrahydropyridazino(4,5-b)quinoline-1,10-dione and the use thereof for the treatment of pain |
Country Status (7)
Country | Link |
---|---|
US (1) | US6933297B2 (fr) |
EP (1) | EP1325003B1 (fr) |
JP (1) | JP2004509964A (fr) |
AT (1) | ATE334982T1 (fr) |
AU (1) | AU2001292499A1 (fr) |
DE (1) | DE60121978D1 (fr) |
WO (1) | WO2002026740A1 (fr) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6946463B2 (en) * | 2000-09-29 | 2005-09-20 | Astrazeneca Ab | 1,2,5,10-tetrahydropyridazino[4,5-b]quinoline-1,10-diones and their use for the treatment of pain |
DE112005001286A5 (de) * | 2004-06-09 | 2007-05-24 | Abb Technology Ag | Gasisolierte Schaltanlage mit ein Sichtfenster zur optischen Erfassung die Schaltstellung der Schaltkontakten |
WO2008153801A1 (fr) * | 2007-05-29 | 2008-12-18 | Intrexon Corporation | Ligands diacylhydrazine chiraux destinés à moduler l'expression de gènes exogènes par le biais d'un complexe récepteur de l'ecdysone |
RU2711968C1 (ru) * | 2018-11-22 | 2020-01-24 | федеральное государственное бюджетное образовательное учреждение высшего образования "Пермский национальный исследовательский политехнический университет" | Анальгезирующее средство |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL111266A (en) | 1993-10-22 | 2002-03-10 | Zeneca Ltd | 2-HETEROARYL OR 2-ARYLPYRIDAZINO [4,5-b] QUINOLINE - 1, 10 - DIONES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
GB9507318D0 (en) | 1995-04-07 | 1995-05-31 | Zeneca Ltd | Alpha substituted pyridazino quinoline compounds |
JP2003518500A (ja) | 1999-12-23 | 2003-06-10 | アストラゼネカ・アクチエボラーグ | 痛みの処置のための方法および組成物 |
US20030153571A1 (en) * | 1999-12-23 | 2003-08-14 | Brown Dean Gordon | Method and composition for the treatment of pain |
US6946463B2 (en) * | 2000-09-29 | 2005-09-20 | Astrazeneca Ab | 1,2,5,10-tetrahydropyridazino[4,5-b]quinoline-1,10-diones and their use for the treatment of pain |
-
2001
- 2001-09-28 JP JP2002531124A patent/JP2004509964A/ja active Pending
- 2001-09-28 AU AU2001292499A patent/AU2001292499A1/en not_active Abandoned
- 2001-09-28 EP EP01972861A patent/EP1325003B1/fr not_active Expired - Lifetime
- 2001-09-28 AT AT01972861T patent/ATE334982T1/de not_active IP Right Cessation
- 2001-09-28 DE DE60121978T patent/DE60121978D1/de not_active Expired - Lifetime
- 2001-09-28 US US10/381,922 patent/US6933297B2/en not_active Expired - Fee Related
- 2001-09-28 WO PCT/SE2001/002125 patent/WO2002026740A1/fr active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
EP1325003B1 (fr) | 2006-08-02 |
DE60121978D1 (de) | 2006-09-14 |
WO2002026740A1 (fr) | 2002-04-04 |
US6933297B2 (en) | 2005-08-23 |
JP2004509964A (ja) | 2004-04-02 |
EP1325003A1 (fr) | 2003-07-09 |
US20040053930A1 (en) | 2004-03-18 |
ATE334982T1 (de) | 2006-08-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GEP20053602B (en) | Aripiprazole for Oral Administration | |
HUP0100437A2 (hu) | Szabályzott felszabadulású gyógyszerkészítmény tolterodin adagolására | |
TR200000129T2 (tr) | Yepyeni spiroazabisiklik heterosiklik bileşikler. | |
AU7031500A (en) | Therapeutic quinazoline compounds | |
BRPI0108977B8 (pt) | compostos azacíclicos, composição farmacêutica e uso de um composto ou sal farmaceuticamente aceitável do mesmo | |
DE60316779D1 (de) | Thiadiazolylpiperazinderivate geeignet für die behandlung bzw. prävention von schmerzen | |
GEP20063895B (en) | Platinum derivative pharmaceutical formulations | |
PT840601E (pt) | Thip para o tratamento de desordens do sono | |
HUP0102728A2 (hu) | Módszerek és transzdermális készítmények fájdalom csillapítására | |
BR0211305A (pt) | Composto, composição farmacêutica, método de tratamento ou prevenção de doenças ou condições e uso de um composto | |
WO1992019617A3 (fr) | Composes de dibenzoxazepine substituee, compositions pharmaceutiques et procedes d'utilisation | |
GEP20022801B (en) | Pyridazino [4,5-B]-Quinoline 5-Oxide Derivatives, Their Preparation and Their Use as Glycine Antagonists | |
MY137752A (en) | Medicament for treating aseptic inflammations containing anemonin as effective component | |
GB9907571D0 (en) | Compounds | |
AU2001246999A1 (en) | New neurokinin antagonists for use as medicaments | |
HU9802897D0 (en) | Optically active pyridyl-4h-1,2,4-oxadiazine derivatives, the use thereof in the treatment of vascular diseases and pharmaceutical composition containing the compound as active ingredient | |
AU2001292499A1 (en) | 7-chloro-4-hydroxy-2-(2-pyridylethyl)-1,2,5,10- tetrahydropyridazino(4,5-b)quinoline-1,10-dione and the use thereof for the treatment of pain | |
TW200503666A (en) | Treatment of type 1 diabetes with pde5 inhibitors | |
AU3308099A (en) | Method for the treatment of pain, including chronic and female specific pain | |
BG105434A (en) | Sertraline oral concentrate | |
WO2001068076A8 (fr) | Enantiomere en d de la dfmo et ses procedes d'utilisation | |
MY133596A (en) | Compound and method for the treatment of pain | |
BR9908838A (pt) | Uso de um glicocorticóide, processeo para tratar glomerulonefrite aguda ou crÈnica, e, composição farmacêutica para tratar glomerulonefrite | |
GEP20053512B (en) | S-Methyl-Dihydro-Ziprasidone for Treatment of Psychiatric and Ocular Disorders. | |
AU8900498A (en) | Compounds and pharmaceutical compositions thereof for eliciting analgesic effects |